SEC Filing · 6-K
PRF Technologies Ltd.
SEC Filing
Press release in this filing
PRF Technologies and Dotz Nano Sign Term Sheet for Strategic Collaboration to Expand →Company context
We are a specialty pharmaceutical company focused on the reformulation of established therapeutics. Our proprietary extended-release drug-delivery system is designed to provide an extended period of post-surgical pain relief without the need for repeated dose administration while reducing the potential need for the use of opiates. In March 2025, we acquired the business operations related to an AI-driven solar analytics technology, DeepSolar.
Current securities
As-filed source
As filedOpen full document ↗